Title Credit Type Event date Costsort descending
Understanding when Assays become Investigational Assays
    • 1.00 Participation
 Enduring $0.00
Activation 101- Who are the Players
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
 Enduring $0.00
Creating your Clinical Trial Protocol
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
 Enduring $0.00
Activation 201- What is the Role of the Activation PM
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
 Enduring $0.00
Two Successful Clinical Trialists Reflect on How They Got Their Start
    • 1.00 Participation
 Enduring $0.00
What is a “Critical Path” and How Can it Help Me?
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
 Enduring $0.00
Protocol Amendments vs. Administrative Letters
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
 Enduring $0.00
Project Management of CPO Trial Activation 101
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
 Enduring $0.00
IIT- Protocol Amendments
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
 Enduring $0.00
Regulatory and Clinical Development Considerations for Chimeric Antigen Receptor (CAR) T Cells
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
 Enduring $0.00
5 Tips for Developing and Maintaining an IND
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
 Enduring $0.00
The "Tiny" Details that Can Wreak Havoc with a Protocol: Improve Protocol Development to Avoid Amendments
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
 Enduring $0.00
Everything that a PI Needs to Know about Holding an IND
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
 Enduring $0.00
Site Perspective: Examine the Process for Maintaining Quality and Ensuring Results
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
 Enduring $0.00
IND Boot Camp
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Participation
 Enduring $0.00

Pages